| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.001 | 0.996 | Hypoxia-inducible factor 1 alpha inhibitor | 0.996 0.001 DBMET00759 | DBMET00759 | |
| 0.995 | 0.003 | 0.995 | Antiinflammatory | 0.987 0.003 DBMET00759 | ||
| 0.973 | 0 | 0.973 | Corticosteroid-like | 0.812 0 DBMET00759 | ||
| 0.97 | 0.001 | 0.97 | Antipruritic | 0.926 0.002 DBMET00759 | ||
| 0.966 | 0.004 | 0.966 | Toll-Like receptor agonist | 0.948 0.004 DBMET00759 | ||
| 0.966 | 0.003 | 0.966 | Toll-Like receptor 7 agonist | 0.948 0.004 DBMET00759 | ||
| 0.946 | 0.002 | 0.946 | Androgen antagonist | 0.58 0.003 DBMET00759 | ||
| 0.94 | 0 | 0.94 | Lipocortins synthesis agonist | 0.863 0 DBMET00759 | ||
| 0.923 | 0 | 0.923 | Glucocorticoid agonist | 0.839 0 DBMET00759 | ||
| 0.917 | 0.005 | 0.917 | Transcription factor NF kappa B inhibitor | 0.773 0.015 DBMET00759 | ||
| 0.902 | 0.001 | 0.902 | Glucocorticoid antagonist | 0.736 0.001 DBMET00759 | ||
| 0.857 | 0.003 | 0.857 | Immunosuppressant | 0.817 0.003 DBMET00759 | ||
| 0.754 | 0 | 0.754 | Arachidonic acid antagonist | 0.693 0 DBMET00759 | ||
| 0.587 | 0.002 | 0.587 | Androgen agonist | 0.466 0.002 DBMET00759 | ||
| 0.504 | 0.004 | 0.504 | Lipocortins synthesis antagonist | 0.465 0.005 DBMET00759 | ||
| 0.465 | 0.005 | 0.465 | NOS3 expression enhancer | 0.203 0.04 DBMET00759 | ||
| 0.46 | 0.008 | 0.46 | Interferon gamma antagonist | 0.329 0.016 DBMET00759 | ||
| 0.432 | 0.004 | 0.432 | Aromatase inhibitor | 0.087 0.025 DBMET00759 | ||
| 0.486 | 0.079 | 0.486 | Apoptosis agonist | 0.452 0.09 DBMET00759 | ||
| 0.397 | 0.022 | 0.397 | DNA synthesis inhibitor | 0.269 0.056 DBMET00759 | ||
| 0.374 | 0.027 | 0.374 | Sodium/bile acid cotransporter inhibitor | 0.374 0.027 DBMET00759 | ||
| 0.269 | 0.004 | 0.269 | Progesterone antagonist | 0.059 0.015 DBMET00759 | ||
| 0.266 | 0.011 | 0.266 | Interleukin 4 antagonist | |||
| 0.292 | 0.042 | 0.306 | Nitric oxide antagonist | 0.306 0.039 DBMET00759 | DBMET00759 | |
| 0.229 | 0.002 | 0.229 | Anabolic | 0.198 0.004 DBMET00759 | ||
| 0.241 | 0.054 | 0.241 | Anesthetic general | |||
| 0.183 | 0.009 | 0.183 | Estrogen agonist | 0.112 0.015 DBMET00759 | ||
| 0.173 | 0.008 | 0.173 | Interleukin 5 antagonist | 0.107 0.034 DBMET00759 | ||
| 0.173 | 0.017 | 0.173 | Estrogen antagonist | 0.158 0.021 DBMET00759 | ||
| 0.203 | 0.062 | 0.253 | P-glycoprotein inhibitor | 0.253 0.04 DBMET00759 | DBMET00759 | |
| 0.202 | 0.064 | 0.202 | Hepatoprotectant | 0.199 0.066 DBMET00759 | ||
| 0.18 | 0.05 | 0.18 | Lipid peroxidase inhibitor | |||
| 0.155 | 0.026 | 0.155 | Antineoplastic alkaloid | 0.075 0.072 DBMET00759 | ||
| 0.13 | 0.003 | 0.13 | Nitric oxide donor | 0.115 0.004 DBMET00759 | ||
| 0.126 | 0.008 | 0.126 | 5-Alpha-reductase inhibitor | 0.078 0.013 DBMET00759 | ||
| 0.143 | 0.032 | 0.143 | Antineoplastic antibiotic | 0.106 0.043 DBMET00759 | ||
| 0.11 | 0.005 | 0.11 | RNA-directed RNA polymerase stimulant | 0.074 0.009 DBMET00759 | ||
| 0.111 | 0.018 | 0.111 | T cell inhibitor | |||
| 0.232 | 0.14 | 0.232 | Interleukin 2 agonist | 0.225 0.149 DBMET00759 | ||
| 0.087 | 0.004 | 0.087 | Progesterone agonist | 0.046 0.005 DBMET00759 | ||
| 0.089 | 0.009 | 0.089 | Mineralocorticoid receptor antagonist | 0.06 0.02 DBMET00759 | ||
| 0.195 | 0.118 | 0.195 | Antioxidant | |||
| 0.101 | 0.031 | 0.101 | Glycine receptor antagonist | |||
| 0.068 | 0.005 | 0.068 | Glucose-6-phosphate dehydrogenase inhibitor | 0.056 0.008 DBMET00759 | ||
| 0.074 | 0.013 | 0.074 | Aldosterone antagonist | |||
| 0.121 | 0.06 | 0.16 | Microtubule formation inhibitor | 0.16 0.033 DBMET00759 | DBMET00759 | |
| 0.095 | 0.037 | 0.095 | Na+ K+ transporting ATPase inhibitor | |||
| 0.105 | 0.055 | 0.107 | Estrogen receptor beta antagonist | 0.107 0.051 DBMET00759 | DBMET00759 | |
| 0.115 | 0.069 | 0.115 | Interleukin 8 antagonist | |||
| 0.055 | 0.016 | 0.055 | Estrogen receptor alpha agonist | |||
| 0.126 | 0.091 | 0.128 | Farnesoid X receptor antagonist | 0.128 0.087 DBMET00759 | DBMET00759 | |
| 0.064 | 0.035 | 0.064 | Heme oxygenase stimulant | |||
| 0.022 | 0.001 | 0.022 | Transcortin receptor antagonist | 0.005 0.004 DBMET00759 | ||
| 0.103 | 0.084 | 0.103 | Cholesterol synthesis inhibitor | |||
| 0.075 | 0.058 | 0.075 | Estrogen receptor alpha antagonist | |||
| 0.046 | 0.033 | 0.046 | Microtubule stabilization | 0.041 0.04 DBMET00759 | ||
| 0.024 | 0.013 | 0.024 | Estrone sulfatase inhibitor | |||
| 0.012 | 0.008 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.026 | 0.025 | 0.026 | Estrogen receptor beta agonist | |||
| 0.075 | 0.094 | 0.081 | Thioredoxin inhibitor | 0.081 0.079 DBMET00759 | DBMET00759 | |
| 0.194 | 0.226 | 0.288 | Alpha-glucosidase inhibitor | 0.288 0.166 DBMET00759 | DBMET00759 | |
| 0.142 | 0.294 | 0.284 | Transcription factor inhibitor | 0.284 0.164 DBMET00759 | DBMET00759 | |
| 0.073 | 0.352 | 0.459 | Thioredoxin glutathione reductase inhibitor | 0.459 0.038 DBMET00759 | DBMET00759 | |
| 0.041 | 0.513 | 0.134 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.131 DBMET00759 | DBMET00759 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |